Synapse Biomedical Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Private

  • Employees
  • 32

Employees

  • Latest Deal Type
  • Later Stage VC
  • (Cancelled)

  • Investors
  • 3

Synapse Biomedical General Information

Description

Developer of diaphragm pacemakers designed to research, develop, and commercialize life-altering neurostimulation products for clinicians. The company's products focus on the treatment of neurodegenerative diseases and amyotrophic lateral sclerosis (ALS) through the use of diaphragm pacing systems (DPS) and other systems, enabling clinicians to reach beyond current methods of treatment to meet the ventilatory needs of people dependent on mechanical ventilation due to spinal cord injuries.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 300 Artino Street
  • Oberlin, OH 44074
  • United States
+1 (440)
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Vertical(s)
Corporate Office
  • 300 Artino Street
  • Oberlin, OH 44074
  • United States
+1 (440)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Synapse Biomedical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 20-Dec-2022 Cancelled Generating Revenue
8. Secondary Transaction - Private 01-May-2021 Completed Generating Revenue
7. Debt - PPP 07-Apr-2020 Completed Generating Revenue
6. Later Stage VC (Series D) 01-Jan-2015 Completed Generating Revenue
5. Grant 18-Dec-2013 Completed Generating Revenue
4. Later Stage VC (Series C) 09-Feb-2010 Completed Generating Revenue
3. Early Stage VC (Series B) 13-Apr-2006 Completed Generating Revenue
2. Early Stage VC (Series A) 20-Sep-2005 $550K $6.3M Completed Generating Revenue
1. Angel (individual) 16-Dec-2003 $5.75M $5.75M Completed Startup
To view Synapse Biomedical’s complete valuation and funding history, request access »

Synapse Biomedical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D
Series C
Series B 3,522,117 $0.010000 $0.06 $0.77 $0.77 1x $0.77 13.21%
Series A 919,633 $0.010000 $0.64 $0.64 1x $0.64 3.45%
To view Synapse Biomedical’s complete cap table history, request access »

Synapse Biomedical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of diaphragm pacemakers designed to research, develop, and commercialize life-altering neurostimulation produc
Therapeutic Devices
Oberlin, OH
32 As of 2024

Vancouver, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Synapse Biomedical Competitors (1)

One of Synapse Biomedical’s competitors is Lungpacer, a Venture Capital-Backed company based in Vancouver, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Lungpacer Venture Capital-Backed Vancouver, Canada
You’re viewing 1 of 1 competitors. Get the full list »

Synapse Biomedical Patents

Synapse Biomedical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230001201-A1 Systems and methods for treating sleep apnea using neuromodulation Pending 29-Jan-2019
US-11471683-B2 Systems and methods for treating sleep apnea using neuromodulation Active 29-Jan-2019
US-20200238084-A1 Systems and methods for treating sleep apnea using neuromodulation Active 29-Jan-2019
US-20180036033-A1 Systems and methods for electrode placement in deep muscles and nerves using ultrasound guidance Inactive 03-Aug-2016
US-8478412-B2 Method of improving sleep disordered breathing Active 30-Oct-2007 A61N1/3601
To view Synapse Biomedical’s complete patent history, request access »

Synapse Biomedical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Synapse Biomedical Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ohio Third Frontier Limited Partner
Vivo Capital Venture Capital Minority
Jumpstart Ventures Venture Capital Minority
To view Synapse Biomedical’s complete investors history, request access »

Synapse Biomedical FAQs

  • When was Synapse Biomedical founded?

    Synapse Biomedical was founded in 2002.

  • Where is Synapse Biomedical headquartered?

    Synapse Biomedical is headquartered in Oberlin, OH.

  • What is the size of Synapse Biomedical?

    Synapse Biomedical has 32 total employees.

  • What industry is Synapse Biomedical in?

    Synapse Biomedical’s primary industry is Therapeutic Devices.

  • Is Synapse Biomedical a private or public company?

    Synapse Biomedical is a Private company.

  • What is Synapse Biomedical’s current revenue?

    The current revenue for Synapse Biomedical is .

  • How much funding has Synapse Biomedical raised over time?

    Synapse Biomedical has raised $20.1M.

  • Who are Synapse Biomedical’s investors?

    Ohio Third Frontier, Vivo Capital, and Jumpstart Ventures have invested in Synapse Biomedical.

  • Who are Synapse Biomedical’s competitors?

    Lungpacer is a competitor of Synapse Biomedical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »